EP3727426
INKRETÍN HLIÐSTÆÐUR OG NOTKUN ÞEIRRA
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
14.12.2018EP published:
26.11.2025EP application number:
18830618.7
EP translation filed:
30.1.2026Grant published:
11.2.2026EPO information:
European Patent Register
Max expiry date:
13.12.2038Expiry date:
13.12.2026Next due date:
31.12.2026
Title in English:
INCRETIN ANALOGS AND USES THEREOFLanguage of the patent:
English
Timeline
Today
14.12.2018EP application
26.11.2025EP Publication
30.1.2026Translation submitted
11.2.2026Registration published
13.12.2026Expires
Owner
Name:
Eli Lilly and CompanyAddress:
Lilly Corporate Center, Indianapolis, IN 46285, US
Inventor
Name:
ALSINA-FERNANDEZ, JorgeAddress:
Indianapolis, Indiana 46206-6288, US
Name:
COSKUN, TamerAddress:
Indianapolis, Indiana 46206-6288, US
Name:
GUO, LiliAddress:
Indianapolis, Indiana 46206-6288, US
Name:
QU, HongchangAddress:
Indianapolis, Indiana 46206-6288, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201762608613 PDate:
21.12.2017Country:
US
Classification
Categories:
A61K 38/26, C07K 14/605, A61K 47/54, A61P 3/04, A61P 3/06, A61P 3/10
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 29.12.2025
Expires: 13.12.2026
Payer: Árnason Faktor ehf.